Business Context and Reporting Period
Company: OrthoPediatrics Corp.
Filing Type: Form 8-K (Current Report)
Date of Report: January 12, 2021
Reporting Period: This filing reports on events occurring on January 12, 2021, specifically regarding upcoming investor presentations.
Key Financial Metrics
This Form 8-K does not contain financial statements, revenue figures, profit data, cash flow, margins, debt levels, or liquidity metrics. The filing serves solely to disclose the use of an investor presentation for upcoming meetings.
Material Changes
No material changes to financial performance or operations are reported in this document. The filing discloses that executive officers intend to use the material in Exhibit 99.1 (Investor Presentation dated January 2021) for upcoming presentations to investors and analysts.
Guidance, Outlook, and Risks
Management Commentary: The filing notes that the information provided, including the attached investor presentation, is furnished pursuant to Item 7.01 of Regulation FD.
Legal Status of Information: The content is explicitly stated not to be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934 and is not incorporated by reference into other filings unless expressly stated.
Risks and Contingencies: No specific risks or contingencies are detailed in this text.
Investor Verification Checklist
- Review Exhibit 99.1 (OrthoPediatrics Corp. Investor Presentation dated January 2021) for actual financial data and strategic outlook, as this 8-K only references the document.
- Verify the trading symbol "KIDS" on the Nasdaq Global Market for current stock performance.
- Confirm that the investor presentation materials are not legally "filed" documents under Section 18 of the Exchange Act, limiting liability for forward-looking statements contained therein.
- Check subsequent filings (e.g., 10-Q or 10-K) for audited or reviewed financial metrics, as this report contains none.